Diversified End MarketsCTS’s structural shift to diversified end markets (industrial, medical, A&D) reduces reliance on cyclical auto volumes. Growing exposure to medical and industrial markets improves revenue stability, increases design‑in opportunities for higher‑value products, and supports steadier long‑term margins and growth.
Margin Expansion And ProfitabilitySustained gross margin improvement (~39.5%, +250bps YoY) points to durable operational gains and favorable mix toward higher‑margin markets. Strong underlying margins support free cash flow, fund reinvestment and returns, and provide a cushion through demand cycles, strengthening long‑term profitability.
Strong Cash Generation & Low LeverageConsistent TTM free cash flow (~$88M) and high cash conversion (~85% of net income), alongside modest leverage (debt/equity ~0.22), create durable financial flexibility. This supports capex for capacity, targeted M&A, and shareholder returns without materially stressing the balance sheet in normal cycles.